United Capital Financial Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Sell |
2,234
-122
| -5% | -$64.1K | 0.01% | 546 |
|
|
2025
Q1 | $1.49M | Sell |
2,356
-14
| -0.6% | -$8.88K | 0.01% | 478 |
|
|
2024
Q4 | $1.69M | Sell |
2,370
-631
| -21% | -$450K | 0.01% | 452 |
|
|
2024
Q3 | $3.16M | Sell |
3,001
-26
| -0.9% | -$27.3K | 0.03% | 330 |
|
|
2024
Q2 | $3.18M | Buy |
3,027
+32
| +1% | +$33.6K | 0.03% | 330 |
|
|
2024
Q1 | $2.88M | Sell |
2,995
-336
| -10% | -$323K | 0.02% | 361 |
|
|
2023
Q4 | $2.93M | Sell |
3,331
-1,106
| -25% | -$971K | 0.02% | 353 |
|
|
2023
Q3 | $3.65M | Sell |
4,437
-232
| -5% | -$191K | 0.02% | 343 |
|
|
2023
Q2 | $3.35M | Buy |
4,669
+74
| +2% | +$53.2K | 0.02% | 368 |
|
|
2023
Q1 | $3.78M | Buy |
4,595
+859
| +23% | +$706K | 0.02% | 354 |
|
|
2022
Q4 | $2.7M | Buy |
3,736
+2,176
| +139% | +$1.57M | 0.02% | 430 |
|
|
2022
Q3 | $1.07M | Buy |
1,560
+52
| +3% | +$35.8K | 0.01% | 597 |
|
|
2022
Q2 | $891K | Sell |
1,508
-49
| -3% | -$29K | ﹤0.01% | 653 |
|
|
2022
Q1 | $1.09M | Sell |
1,557
-72
| -4% | -$50.3K | 0.01% | 645 |
|
|
2021
Q4 | $1.03M | Sell |
1,629
-86
| -5% | -$54.3K | ﹤0.01% | 667 |
|
|
2021
Q3 | $1.04M | Sell |
1,715
-216
| -11% | -$131K | 0.01% | 668 |
|
|
2021
Q2 | $1.08M | Sell |
1,931
-383
| -17% | -$214K | 0.01% | 671 |
|
|
2021
Q1 | $1.1M | Sell |
2,314
-58
| -2% | -$27.4K | 0.01% | 640 |
|
|
2020
Q4 | $1.15M | Buy |
2,372
+281
| +13% | +$136K | 0.01% | 640 |
|
|
2020
Q3 | $1.17M | Buy |
2,091
+62
| +3% | +$34.7K | 0.01% | 614 |
|
|
2020
Q2 | $1.27M | Buy |
2,029
+829
| +69% | +$517K | 0.01% | 599 |
|
|
2020
Q1 | $586K | Buy |
1,200
+314
| +35% | +$153K | ﹤0.01% | 763 |
|
|
2019
Q4 | $332K | Buy |
886
+522
| +143% | +$196K | ﹤0.01% | 1093 |
|
|
2019
Q3 | $101K | Sell |
364
-589
| -62% | -$163K | ﹤0.01% | 1228 |
|
|
2019
Q2 | $298K | Buy |
953
+304
| +47% | +$95.1K | ﹤0.01% | 1199 |
|
|
2019
Q1 | $266K | Sell |
649
-691
| -52% | -$283K | ﹤0.01% | 1155 |
|
|
2018
Q4 | $500K | Buy |
1,340
+63
| +5% | +$23.5K | ﹤0.01% | 919 |
|
|
2018
Q3 | $516K | Buy |
1,277
+674
| +112% | +$272K | ﹤0.01% | 963 |
|
|
2018
Q2 | $208K | Sell |
603
-80
| -12% | -$27.6K | ﹤0.01% | 1214 |
|
|
2018
Q1 | $235K | Buy |
683
+123
| +22% | +$42.3K | ﹤0.01% | 1182 |
|
|
2017
Q4 | $214K | Sell |
560
-28
| -5% | -$10.7K | ﹤0.01% | 1217 |
|
|
2017
Q3 | $263K | Buy |
588
+107
| +22% | +$47.9K | ﹤0.01% | 1156 |
|
|
2017
Q2 | $236K | Buy |
+481
| New | +$236K | ﹤0.01% | 1154 |
|
|
2016
Q4 | – | Sell |
-576
| Closed | -$232K | – | 1308 |
|
|
2016
Q3 | $232K | Buy |
+576
| New | +$232K | ﹤0.01% | 1146 |
|
|
2015
Q4 | – | Sell |
-636
| Closed | -$296K | – | 1273 |
|
|
2015
Q3 | $296K | Buy |
636
+120
| +23% | +$55.8K | ﹤0.01% | 1061 |
|
|
2015
Q2 | $263K | Buy |
+516
| New | +$263K | ﹤0.01% | 1112 |
|